The Burrill Report
The Burrill Report
Stop FollowingThe Burrill Report
ABOUT
The Burrill Report is written for everyone who wants to understand how biotechnology operates as a business. Each month the publication focuses on the health of the industry and the strategies that will be needed to be successful. It provides actionable market intelligence on the latest global developments and trends in the life sciences industry. Available monthly, subscribers also benefit from monthly and quarterly market financial and business statistics on:
- Public companies
- venture financings
- Project Runway – Follow the global life sciences companies filing for and completing their IPOs – and their post market performances
- Clinical Trials successes and failures ...More
- Patent
- M&A and Partnering deals
- Periodic country features on Canada, Europe and emerging countries such as China & India.
In addition, BR provides in-depth coverage on specific sectors of life sciences including: Personalized Medicine; Diagnostics, Medical Devices and Biogreentech (Ag-Bio and Biofuels/Bioenergy). Through weekly Burrill Indices, the progress and prospects of biotech companies by size, from small through to blue-chip are also tracked.
Visit: The Burrill Report to obtain your sample issue (http://www.burrillreport.com/)
- Public companies
- venture financings
- Project Runway – Follow the global life sciences companies filing for and completing their IPOs – and their post market performances
- Clinical Trials successes and failures ...More
- Patent
- M&A and Partnering deals
- Periodic country features on Canada, Europe and emerging countries such as China & India.
In addition, BR provides in-depth coverage on specific sectors of life sciences including: Personalized Medicine; Diagnostics, Medical Devices and Biogreentech (Ag-Bio and Biofuels/Bioenergy). Through weekly Burrill Indices, the progress and prospects of biotech companies by size, from small through to blue-chip are also tracked.
Visit: The Burrill Report to obtain your sample issue (http://www.burrillreport.com/)
SNAPSHOT
- Description: Journalist. Trading frequency: Not Trading
- Interests: Stocks - long
COMPANY
Burrill & Company
Burrill Media, part of Burrill & Company, a San Francisco-based global leader in life sciences with activities in Venture Capital, Private Equity, Merchant Banking and Media (www.burrillandco.com), publishes a wide range of bio-intelligence reports including: the annual State of the Industry, The Burrill ...More
Report, Burrill Canadian Biotech News, The Burrill Report Weekly Brief, The Personalized Medicine Report, The Stem Cell Report, and the Consumer Digital Health Report.
Burrill Media is also the sponsor and facilitator of leading industry conferences worldwide including: The Biotech Meeting, The Burrill Pan-Asia Life Sciences Meeting, Burrill Latin America Life Sciences Conference, The Burrill Personalized Medicine Meeting, The Burrill Consumer Digital Health Meeting, and The Aging Meeting.
BLOG
The Burrill Report
The Burrill Report (BR) provides actionable market intelligence on the latest global developments and trends in the life sciences industry. Available bi-monthly, subscribers also benefit from monthly market updates and financial and business statistics provided in a special premium area on the Burrill Report ...More
Website
Book
Biotech 2012: Innovating in the New Austerity
Biotech 2012: Innovating in the New Austerity
Considered required reading by executives in the life sciences industry, this book is an invaluable, one-stop resource for making sense of today¹s changing landscape. Innovating in the New Austerity:
Provides analysis of the life sciences industry with data, ...More
graphs, and industry highlights including new product approvals, advances in technology, and details of financing and M&A transactions
Examines how pharmaceutical companies are reinventing themselves to innovate for less in this era of austerity
Tracks the convergence of wireless, mobile, and Internet technologies transforming the economics and delivery of healthcare worldwide
Explores the impact of graying populations on healthcare around the world and how regenerative therapies may slow or reverse the diseases of aging
Gives a detailed view of the rise of emerging markets and how these economies are moving from being centers of low-cost manufacturing to world class innovation
Explains the challenges biofuels developers face in expanding their production to commercial scale
Analyzes the global interplay between business, policy, regulation, and reimbursement Comprehensive, unparalleled coverage of key trends makes Innovating in the New Austerity a critical resource for life sciences professionals.
Download the table of Contents, list of charts, and the entire first chapter for free at http://www.burrillandco.com/resources.html
Latest comments on The Burrill's Articles
more »
- Windsun33 on Horizon Pharma's IPO Stays Stuck in Narrow Range
- stmf45@yahoo.com on Horizon Pharma's IPO Stays Stuck in Narrow Range
- steveto on Amyris Finds Scaling Up More Difficult Than Exp...
- Gary Head on Affymax's Anemia Drug Will Create Added Competi...
- AndrewLMS on Merrimack IPO Falls Out Of The Gate
LATEST ARTICLES & INSTAPOSTS
more »



